PRESS RELEASE published on 04/05/2024 at 10:00, 2 years 1 month ago New Hope in Battle Against C. diff: New Surface "Active" Technology with Residual Efficacy Kills Spores in 30 Seconds Primel releases study results showing Active Hand Coating's high sporicidal activity against C. diff under clean & dirty conditions. Breakthrough technology reduces transmission rates & enhances safety Primel Infection Prevention Active Hand Coating C. Diff Pathogen
PRESS RELEASE published on 04/05/2024 at 09:45, 2 years 1 month ago neurocare group AG Welcomes Norman Erhard as Senior VP Europe & Latin America neurocare group AG appoints Norman Erhard as Senior VP Europe & Latin America, enhancing global leadership team with extensive experience in medical devices and clinic networks sector Europe Latin America Senior VP Norman Erhard Neurocare Group AG
PRESS RELEASE published on 04/05/2024 at 09:41, 2 years 1 month ago Petrofac Limited: Director/PDMR shareholding Petrofac Limited confirms purchase of ordinary shares by Directors as per Market Abuse Regulation 19. Details of shares bought and total interest disclosed Shares Shareholding Director Petrofac Limited Market Abuse Regulation 19
PRESS RELEASE published on 04/05/2024 at 09:40, 2 years 1 month ago Electrical vehicle charging station operator ZES and electrip join Hubject's global intercharge roaming network ZES and electrip partner with Hubject to enhance e-roaming solutions for EV drivers in Turkey and Europe, aiming to make electric vehicles more accessible and reduce carbon emissions Electric Vehicles ZES Hubject Electrip E-roaming Solutions
PRESS RELEASE published on 04/05/2024 at 09:30, 2 years 1 month ago Heidelberg Pharma to host R&D Webinar following novel data presented at AACR Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
PRESS RELEASE published on 04/05/2024 at 09:00, 2 years 1 month ago beaconsmind Group: First Berlin continues to rate beaconsmind share as 'Buy' – Price target EUR 14.00 First Berlin Equity Research GmbH continues to rate beaconsmind stock as 'Buy' with a target price of EUR 14.00, citing significant price potential of 190%. beaconsmind Group announces major contracts and strategic acquisitions Digital Transformation M&A Activities Target Price Beaconsmind Stock Rating
PRESS RELEASE published on 04/05/2024 at 09:00, 2 years 1 month ago Jericho to Amend Terms of Debentures and Warrants and Shares for Interest Debt Settlement Jericho Energy Ventures Inc. applies to amend conversion price and extend maturity of outstanding debentures and warrants issued in private placement, subject to TSXV approval Private Placement TSX Venture Exchange Jericho Energy Ventures Inc. Maturity Extension Conversion Price
REGULATED PRESS RELEASE published on 04/05/2024 at 08:59, 2 years 1 month ago Mars 2024 - Déclaration sur le nombre d'actions composant le capital social et le nombre de droits de vote correspondant bioMérieux communique les informations mensuelles relatives au nombre total de droits de vote et d'actions au 31/03/2024 Droits De Vote Code De Commerce BioMérieux Actions Informations Mensuelles
REGULATED PRESS RELEASE published on 04/05/2024 at 08:45, 2 years 1 month ago BAIKOWSKI : Rapport financier annuel 2023
REGULATED PRESS RELEASE published on 04/05/2024 at 08:45, 2 years 1 month ago BAIKOWSKI : Mise à disposition du rapport financier annuel 2023 Baikowski annonce la mise à disposition de son rapport financier annuel 2023 auprès du public et de l'AMF. Prochain RDV : chiffre d'affaires 1er semestre 2024 le 26 juillet Chiffre D'affaires AMF Euronext Growth Baikowski Rapport Financier Annuel
Published on 05/09/2026 at 01:30, 10 hours 52 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 12 hours 22 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 15 hours 43 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 17 hours 9 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 17 hours 19 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 17 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 17 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 17 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 17 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL